E
Translational Development Acquisition Corp. TDAC
$10.17 -$0.01-0.10% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -70.90K -546.70K -485.90K -485.70K -485.50K
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- 482.30K 482.30K 482.30K 482.30K
Total Other Non-Cash Items -120.70K 1.60K 1.60K 800.00 --
Change in Net Operating Assets -659.90K 22.30K 2.00K 2.50K 3.00K
Cash from Operations -851.50K -40.50K 0.00 -100.00 -200.00
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -174.23M -- -- -- --
Cash from Investing -174.23M -- -- -- --
Total Debt Issued 406.50K 270.00K 70.00K 35.00K --
Total Debt Repaid -800.00K -- -- -- --
Issuance of Common Stock 169.05M -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 6.86M -7.50K -- -- --
Cash from Financing 175.51M 262.50K 70.00K 35.00K --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -200.00 -200.00 -100.00 0.00
Net Change in Cash 436.10K 221.80K 69.80K 34.80K -200.00